"Dotter Inc., a Korean Leading Bioabsorbable Stent Company Announced the Start of Clinical Trial to Evaluate the Safety and Effectiveness of the Company's Drug-Eluting Bioabsorbable Stent Dotter BRS"
24-7 Press Release Service
Telephone Hours
Monday to Friday
8:30am to 5:00pm PST Toll Free
1-888-880-9539 Telephone
646-417-8294 US Address:
Smith Tower Suite 1400 - 506 Second Avenue
Seattle, WA
98104, USA Address:
Suite 203 - 901 West 3rd St.
North Vancouver, BC
V7P 3P9, Canada